DAPT duration in acute coronary syndrome: is stent type an issue?

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	EuroIntervention 2021-08, Vol.17 (5), p.e360-e361
Hauptverfasser:	Gilard, Martine, Didier, Romain
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Coronary Syndrome - drug therapy Acute Coronary Syndrome - surgery Drug Therapy, Combination Drug-Eluting Stents - adverse effects Humans Percutaneous Coronary Intervention - adverse effects Platelet Aggregation Inhibitors - adverse effects Stents - adverse effects Treatment Outcome
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	e361
container_issue	5
container_start_page	e360
container_title	EuroIntervention
container_volume	17
creator	Gilard, Martine Didier, Romain
description
doi_str_mv	10.4244/EIJV17I5A62
format	Article
fullrecord	<record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_4244_EIJV17I5A62</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>34356030</sourcerecordid><originalsourceid>FETCH-LOGICAL-c284t-d9767e43af3fb7ad16e8dd2deef981f7e3f2178544c648a84ff897a1f7d96c9c2</originalsourceid><addsrcrecordid>eNpNj0tLxDAUhYMoOoyu3Ev2Um0ezcONlJlRKwO6GN2WTHIDBfsgSRf991ZGZVb3wP04nA-ha5Lfccr5_aZ6_SSyKkpBT9CCaKEzQQk7Pcrn6IJxVoic5QtUrsv3HXZjMKnpO9x02NgxAbZ96DsTJhynzoW-hQfcRBwTdAmnaQBsZjjGER4v0Zk3XxGufu8SfTxtdquXbPv2XK3KbWap4ilzWgoJnBnP_F4aRwQo56gD8FoRL4F5SqQqOLeCK6O490pLM3-cFlZbukS3h14b-hgD-HoITTtPrEle_7jXR-4zfXOgh3Hfgvtn_8zpN0QXVfQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>DAPT duration in acute coronary syndrome: is stent type an issue?</title><source>MEDLINE</source><creator>Gilard, Martine ; Didier, Romain</creator><creatorcontrib>Gilard, Martine ; Didier, Romain</creatorcontrib><identifier>ISSN: 1969-6213</identifier><identifier>EISSN: 1969-6213</identifier><identifier>DOI: 10.4244/EIJV17I5A62</identifier><identifier>PMID: 34356030</identifier><language>eng</language><publisher>France</publisher><subject>Acute Coronary Syndrome - drug therapy ; Acute Coronary Syndrome - surgery ; Drug Therapy, Combination ; Drug-Eluting Stents - adverse effects ; Humans ; Percutaneous Coronary Intervention - adverse effects ; Platelet Aggregation Inhibitors - adverse effects ; Stents - adverse effects ; Treatment Outcome</subject><ispartof>EuroIntervention, 2021-08, Vol.17 (5), p.e360-e361</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c284t-d9767e43af3fb7ad16e8dd2deef981f7e3f2178544c648a84ff897a1f7d96c9c2</cites></display><links><openurl>$$Topenurl_article</openurl><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>776</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34356030$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gilard, Martine</creatorcontrib><creatorcontrib>Didier, Romain</creatorcontrib><title>DAPT duration in acute coronary syndrome: is stent type an issue?</title><title>EuroIntervention</title><addtitle>EuroIntervention</addtitle><subject>Acute Coronary Syndrome - drug therapy</subject><subject>Acute Coronary Syndrome - surgery</subject><subject>Drug Therapy, Combination</subject><subject>Drug-Eluting Stents - adverse effects</subject><subject>Humans</subject><subject>Percutaneous Coronary Intervention - adverse effects</subject><subject>Platelet Aggregation Inhibitors - adverse effects</subject><subject>Stents - adverse effects</subject><subject>Treatment Outcome</subject><issn>1969-6213</issn><issn>1969-6213</issn><fulltext>false</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNj0tLxDAUhYMoOoyu3Ev2Um0ezcONlJlRKwO6GN2WTHIDBfsgSRf991ZGZVb3wP04nA-ha5Lfccr5_aZ6_SSyKkpBT9CCaKEzQQk7Pcrn6IJxVoic5QtUrsv3HXZjMKnpO9x02NgxAbZ96DsTJhynzoW-hQfcRBwTdAmnaQBsZjjGER4v0Zk3XxGufu8SfTxtdquXbPv2XK3KbWap4ilzWgoJnBnP_F4aRwQo56gD8FoRL4F5SqQqOLeCK6O490pLM3-cFlZbukS3h14b-hgD-HoITTtPrEle_7jXR-4zfXOgh3Hfgvtn_8zpN0QXVfQ</recordid><startdate>20210801</startdate><enddate>20210801</enddate><creator>Gilard, Martine</creator><creator>Didier, Romain</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20210801</creationdate><title>DAPT duration in acute coronary syndrome: is stent type an issue?</title><author>Gilard, Martine ; Didier, Romain</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c284t-d9767e43af3fb7ad16e8dd2deef981f7e3f2178544c648a84ff897a1f7d96c9c2</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Acute Coronary Syndrome - drug therapy</topic><topic>Acute Coronary Syndrome - surgery</topic><topic>Drug Therapy, Combination</topic><topic>Drug-Eluting Stents - adverse effects</topic><topic>Humans</topic><topic>Percutaneous Coronary Intervention - adverse effects</topic><topic>Platelet Aggregation Inhibitors - adverse effects</topic><topic>Stents - adverse effects</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><creatorcontrib>Gilard, Martine</creatorcontrib><creatorcontrib>Didier, Romain</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>EuroIntervention</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>no_fulltext</fulltext></delivery><addata><au>Gilard, Martine</au><au>Didier, Romain</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>DAPT duration in acute coronary syndrome: is stent type an issue?</atitle><jtitle>EuroIntervention</jtitle><addtitle>EuroIntervention</addtitle><date>2021-08-01</date><risdate>2021</risdate><volume>17</volume><issue>5</issue><spage>e360</spage><epage>e361</epage><pages>e360-e361</pages><issn>1969-6213</issn><eissn>1969-6213</eissn><cop>France</cop><pmid>34356030</pmid><doi>10.4244/EIJV17I5A62</doi><oa>free_for_read</oa></addata></record>
fulltext	no_fulltext
identifier	ISSN: 1969-6213
ispartof	EuroIntervention, 2021-08, Vol.17 (5), p.e360-e361
issn	1969-6213 1969-6213
language	eng
recordid	cdi_crossref_primary_10_4244_EIJV17I5A62
source	MEDLINE
subjects	Acute Coronary Syndrome - drug therapy Acute Coronary Syndrome - surgery Drug Therapy, Combination Drug-Eluting Stents - adverse effects Humans Percutaneous Coronary Intervention - adverse effects Platelet Aggregation Inhibitors - adverse effects Stents - adverse effects Treatment Outcome
title	DAPT duration in acute coronary syndrome: is stent type an issue?
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T08%3A27%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=DAPT%20duration%20in%20acute%20coronary%20syndrome:%20is%20stent%20type%20an%20issue?&rft.jtitle=EuroIntervention&rft.au=Gilard,%20Martine&rft.date=2021-08-01&rft.volume=17&rft.issue=5&rft.spage=e360&rft.epage=e361&rft.pages=e360-e361&rft.issn=1969-6213&rft.eissn=1969-6213&rft_id=info:doi/10.4244/EIJV17I5A62&rft_dat=%3Cpubmed_cross%3E34356030%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/34356030&rfr_iscdi=true